During aging and Alzheimer's disease (AD) the cerebral cortex entorhinal cortex and hippocampus show neuronal loss, cellular and subcellular changes indicating a slow degenerative process. Cerebral cortical pathology is usually associated with degenerative changes in anatomically linked regions. The proposed experiments are aimed. at determining neuronal function, vulnerability, degeneration and repair in anatomical regions prone to AD. I will investigate (1) The resulting pathology and functional consequences of neuronal loss in cerebral cortex, entorhinal cortex and hippocampus. (2) Animal models that mimic mechanisms for slow progressive neuronal loss. (3) Methods that protect intercortical and subcortical systems from degeneration. The specific hypotheses will be tested in models of excitotoxic neuronal degeneration in the rat. The initial neuronal death in these models is induced by exposure of brain regions to N-Methyl-D-Aspartate. To test neuronal stress and vulnerability, local excitotoxic lesion will be made in target deprived cortical and subcortical regions, determining responses to secondary insults likely to occur during neurodegenerative disease. Specific neuronal tracer techniques in combination with morphological, molecular and quantitative neurochemistry will yield results a bout the cellular regulation of neuronal survival. By implanting neuroblasts or genetically engineered cells producing trophic factors into the primary lesions we will investigate the basic capacity for neuronal protection, repair and recovery of function. In particular, entorhinal cortical neuronal damage will be studied at both the cellular and behavioral level to examine the basis for memory dysfunction observed in our preliminary studies. Our focus on pathology and remodeling in regions known to be involved in both AD and aging, as well as creating in vivo conditions simulating accelerated neuronal loss, may reveal basic neurobiological mechanisms underlying these conditions and contribute to discoveries of effective treatments.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29NS029178-03
Application #
3478221
Study Section
Neurology B Subcommittee 2 (NEUB)
Project Start
1991-07-22
Project End
1996-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Mc Lean Hospital (Belmont, MA)
Department
Type
DUNS #
City
Belmont
State
MA
Country
United States
Zip Code
02478
Galpern, W R; Burns, L H; Deacon, T W et al. (1996) Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: functional recovery and graft morphology. Exp Neurol 140:1-13
Galpern, W R; Frim, D M; Tatter, S B et al. (1996) Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration. Cell Transplant 5:225-32
Isacson, O; Deacon, T W (1996) Specific axon guidance factors persist in the adult brain as demonstrated by pig neuroblasts transplanted to the rat. Neuroscience 75:827-37
Freeman, T B; Sanberg, P R; Isacson, O (1995) Development of the human striatum: implications for fetal striatal transplantation in the treatment of Huntington's disease. Cell Transplant 4:539-45
Isacson, O; Deacon, T W; Pakzaban, P et al. (1995) Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat Med 1:1189-94
Pakzaban, P; Deacon, T W; Burns, L H et al. (1995) A novel mode of immunoprotection of neural xenotransplants: masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system. Neuroscience 65:983-96
Deacon, T W; Pakzaban, P; Isacson, O (1994) The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: neural transplantation and developmental evidence. Brain Res 668:211-9
Frim, D M; Wullner, U; Beal, M F et al. (1994) Implanted NGF-producing fibroblasts induce catalase and modify ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatum. Exp Neurol 128:172-80
Wullner, U; Pakzaban, P; Brownell, A L et al. (1994) Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with 11C-CFT. Exp Neurol 126:305-9
Davar, G; Kramer, M F; Garber, D et al. (1994) Comparative efficacy of expression of genes delivered to mouse sensory neurons with herpes virus vectors. J Comp Neurol 339:3-11

Showing the most recent 10 out of 29 publications